# Associated Genes With Atomoxetine Response in Attention Deficit Hyperactivity Disorder (ADHD)

> **NCT01339286** · PHASE4 · UNKNOWN · sponsor: **Peking University** · enrollment: 100 (estimated)

## Conditions studied

- Attention Deficit Hyperactivity Disorder

## Interventions

- **DRUG:** atomoxetine

## Key facts

- **NCT ID:** NCT01339286
- **Lead sponsor:** Peking University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-03
- **Primary completion:** 2011-12
- **Final completion:** —
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2011-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01339286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01339286, "Associated Genes With Atomoxetine Response in Attention Deficit Hyperactivity Disorder (ADHD)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01339286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*